ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 138 filers reported holding ARCELLX INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.9%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 3,946,630 | $141,605,084 | 72.57% |
| NEA Management Company, LLC | 3,745,262 | $134,380,001 | 10.38% |
| Paradigm Biocapital Advisors LP | 2,953,122 | $105,958,017 | 7.19% |
| Samsara BioCapital, LLC | 613,921 | $22,027,485 | 6.74% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,869,967 | $102,974,416 | 5.56% |
| Perceptive Advisors | 3,965,978 | $142,299,291 | 4.75% |
| Cormorant Asset Management, LP | 2,150,000 | $77,142,000 | 4.50% |
| Affinity Asset Advisors, LLC | 400,000 | $14,352,000 | 4.04% |
| Novo Holdings A/S | 1,075,000 | $38,571,000 | 2.85% |
| Soleus Capital Management, L.P. | 643,777 | $23,098,719 | 2.13% |
| Vivo Capital, LLC | 503,565 | $18,067,912 | 1.98% |
| GREAT POINT PARTNERS LLC | 287,500 | $10,315,500 | 1.88% |
| Parkman Healthcare Partners LLC | 203,482 | $7,300,934 | 1.34% |
| HighVista Strategies LLC | 78,028 | $2,799,645 | 1.30% |
| Endurant Capital Management LP | 14,158 | $507,989 | 0.46% |
| PFM Health Sciences, LP | 240,338 | $8,623,327 | 0.41% |
| CLOUGH CAPITAL PARTNERS L P | 102,762 | $3,687,101 | 0.40% |
| CAAS CAPITAL MANAGEMENT LP | 124,959 | $4,483,529 | 0.29% |
| MYDA Advisors LLC | 25,000 | $897,000 | 0.29% |
| Knott David M Jr | 20,000 | $718 | 0.27% |
This page lists ARCELLX INC's shareholders in Q3 2023. To view ARCELLX INC's shareholder history, click here.